Entity Public Float in USD of Processa Pharmaceuticals, Inc. from Q4 2013 to Q2 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Processa Pharmaceuticals, Inc. quarterly Entity Public Float history and change rate from Q4 2013 to Q2 2024.
  • Processa Pharmaceuticals, Inc. Entity Public Float for the quarter ending 28 Jun 2024 was $5.8M, a 43.1% decline year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Processa Pharmaceuticals, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.8M -$4.4M -43.1% 28 Jun 2024 10-K 20 Mar 2025
Q2 2023 $10.2M -$23.6M -69.8% 30 Jun 2023 10-K 29 Mar 2024
Q2 2022 $33.8M -$61.6M -64.6% 30 Jun 2022 10-K 30 Mar 2023
Q2 2021 $95.4M +$73.4M +334% 30 Jun 2021 10-K/A 02 May 2022
Q2 2020 $22M -$22.8M -50.9% 30 Jun 2020 10-K 25 Mar 2021
Q2 2019 $44.8M +$19.5M +77.1% 28 Jun 2019 10-K 06 Mar 2020
Q2 2018 $25.3M +$24.3M +2430% 30 Jun 2018 10-K/A 08 Apr 2019
Q2 2017 $1M -$447K -30.9% 30 Jun 2017 10-K 16 Apr 2018
Q2 2016 $1.45M -$2.5M -63.3% 30 Jun 2016 10-K 25 Sep 2017
Q2 2015 $3.95M -$3.81M -49.1% 30 Jun 2015 10-K 19 Jun 2017
Q2 2014 $7.76M 30 Jun 2014 10-K 14 Apr 2015
Q4 2013 $4.59M 31 Dec 2013 10-K 27 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.